Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets open in green
Fri, 30 Dec 09:30 am

Asian stock markets have opened the day on a firm note. Stock markets in China (up 0.8%), Japan (up 0.3%) and Malaysia (up 0.3%) are in the green. The Indian stock markets have opened the day on a firm note as well. Stocks in the realty and auto space are leading the gains.

The BSE-Sensex is trading higher by 66 points (0.4%) and the NSE-Nifty is higher by around 20 points (0.4%). Mid cap and small cap stocks have opened on a firm note, with the BSE Mid Cap index up by 0.3% while BSE Small Cap is up by 0.2%. The rupee is trading at 53.20 to the US dollar.

Pharma stocks have opened the day on a firm note with Dr Reddy's Laboratories Ltd and Ranbaxy trading in the green. Drug maker, Dr Reddy's Laboratories Ltd has launched a new cream for reducing pain and inflammation in patients with joint pain, arthritis, bursitis, tendinitis among others. The cream has been named as 'Supamove' cream and has been launched in India through an in-licensing deal from the US-based Cymbiotics Inc. The cream will be available in 30 gm tube. Dr Reddy's in-licensed another product from Cymbiotics named Venusa. B introducing this lotion, Dr Reddy's strengthened its emollients and protective product portfolio. According to the IMS, the total market size for non-steroidal anti-inflammatory drug (NSAID) is valued at Rs 2,080 m and is growing at a healthy rate of over 18%.

Oil & gas stocks have opened the day on a firm note with Reliance Industries and Oil & Natural Gas Corporation (ONGC) trading in the green. As per a leading financial daily, state-owned ONGC is planning to set up a number of projects in the nuclear, fertilizer, solar, wind power and lighting sectors. The company will set up a gas-fired fertilizer plant in Tripura. The solar projects would come up in Rajasthan and Gujarat. The wind power project would be set up in Rajasthan. However, the company is yet to finalize the site for the nuclear plant and the light-emitting diode (LED) manufacturing unit. ONGC will set up the nuclear power plant in collaboration with Nuclear Power Corporation of India Ltd (NPCIL) at a mutually agreed location.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets open in green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.